News and Trends 10 Aug 2022 Research discovery may help diagnose and treat cancer and brain disorders …to cause several neurodevelopmental disorders. A better understanding of these events is key to decoding fundamental mechanisms of brain development and revealing novel diagnostics and therapeutic avenues for such disorders…. August 10, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jul 2022 People with hemophilia B could be protected from bleeding by a single dose of a drug currently being trialed …detected. Adverse events related to immune management were consistent with the known safety profiles of corticosteroids and tacrolimus. Prophylactic In the B-AMAZE trial, patients had received one of four doses… July 22, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2022 Japanese research offers hope for Fukuyama muscular dystrophy patients …tubules that gives shape and coherence to living cells. The genetic abnormality in the FKTN gene prevents it from expressing a fully functional form of ribitol-phosphate transferase. This reduced functionality,… December 12, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2023 Sumitomo Pharma Oncology receives orphan drug designation for Ewing sarcoma treatment …alvocidib. Alvocidib binds at the ATP-binding site of CDK9, stopping phosphorylation by CDK9. This binding prevents productive transcription and causes reduction of messenger RNA (mRNA) in genes such as c-MYC… April 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2023 Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’ …to 53%. There were no reported serious or severe adverse events. Data are not yet available for single or multiple dose cohorts at 184 mg, the highest dose being tested…. April 27, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2018 Could We Use CRISPR to Light up Future Christmas Trees? …step of the genetic modification process to visitors at their outreach events. “We worked closely with artists from a London institute and virtual reality programmers to come up with a… December 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 Five key trends shaping life sciences in 2023 …sciences industry. 1. Big pharma will fuel M&A activity There is an industry-wide race for intellectual property and ownership of leading biotechnology innovations. To get it, big pharma is aggressively… January 11, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Feb 2025 Eight respiratory disease companies advancing innovative therapies in 2025 …pulmonary fibrosis being among the most popular indications for biotechs. In this article, we take a look at eight respiratory disease companies advancing novel therapies in 2025. Table of contents… February 27, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Jun 2023 Five latest advancements in osteoporosis research …phase 1 study of RT-102, with the study having achieved all of its endpoints. It was found that the drug was generally well-tolerated with no serious adverse events noted during… June 21, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2022 Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led by RA Capital Management with participation from Bain Capital Life Sciences, BB Biotech AG and… September 22, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Clinical Microbiomics expanding with €10M million investment …– the microbiome. We challenge the idea that the complexity of the microbiome prevents us from exploring its potential to tackle the most pressing health questions of our time. “Seventure… October 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 AstraZeneca’s Airsupra gets US approval as new rescue treatment for asthma …certain financial payments to Avillion, to commercialize Airsuprain in the U.S. This milestone continues Avillion’s 100% successful rate in clinical co-development partnerships for the global pharmaceutical and biotech industry. In… January 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email